Section Arrow
Quote
BDX.NYSE
- Becton Dickinson and Co
Quotes are at least 15-min delayed:2026/11/05 05:45 EST
Pre Market
Last
 207.475
-1.715 (-0.82%)
Bid
187
Ask
208
High 210 
Low 206.5 
Volume 144 
Regular Hours (Closed)
Last
 209.19
+11.02 (+5.56%)
Day High 
209.835 
Prev. Close
198.17 
1-M High
200.47 
Volume 
4.46M 
Bid
187
Ask
208
Day Low
200.3 
Open
203 
1-M Low
176.04 
Market Cap 
53.98B 
Currency 美元 
P/E 34.29 
%Yield 2.01 
10-SMA 197.32 
20-SMA 192.76 
50-SMA 186.88 
52-W High 200.47 
52-W Low 138.347084 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.31/14.21
Enterprise Value
71.60B
Balance Sheet
Book Value Per Share
89.64
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
21.84B
Operating Revenue Per Share
69.92
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc40.35+6.26+18.36%42.65PE
Pre Market 40 -0.35 -0.87%
MMEDMiniMed Group, Inc.19.29+0.44+2.33%-- 
Pre Market 19.4 +0.11 +0.57%
BAXBaxter International26.5+1.01+3.96%-- 
Pre Market 26.79 +0.29 +1.09%
AVTRAvantor15.65+0.06+0.38%31.18PE
Pre Market 15.46 -0.19 -1.21%
WRBYWarby Parker21.29-0.65-2.96%365.67PE
Pre Market 21.3 +0.01 +0.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.